DDI
DDI

Diabetes has affected more than 441,000 adults in Kuwait, becoming an extremely common disease. Diabetes has also proven to increase the risk of developing other diseases like kidney disease, foot problems, blindness, high blood pressure, low blood sugar and heart attack/stroke.

The high prevalence of diabetes creates the need for innovative research, clinical trials and evidence-based patient care. At DDI, we have dedicated our Sectors (Research, Medical, Operations) towards the prevention and treatment of diabetes.

Our Research Sector's experienced teams apply a multi-disciplinary approach in the study of diabetes and its complications to achieve disease-targeted research.

Our Research Sector's experienced teams apply a multi-disciplinary approach in the study of diabetes and its complications to achieve disease-targeted research.

Know More
Our Medical Sector uses a multi-faceted approach to deliver the best medical care and research outcomes by using unique and innovative methods.

Our Medical Sector uses a multi-faceted approach to deliver the best medical care and research outcomes by using unique and innovative methods.

Know More
Our Operations Sector manages service performance, institutional stability, technological proficiency, policy implementation and data management.
<br>

Our Operations Sector manages service performance, institutional stability, technological proficiency, policy implementation and data management.

Know More

DDI's 2018-2023 Strategy

We continuously strive to create a platform that applies our knowledge to translational research, or bench-to-bed: from basic sciences to clinical trials point-of-care applications, scientific findings and drug discoveries. Our five-year strategy allows us to focus on specific research charters, develop focused research projects and translate the findings to clinical applications. By doing so, we can engage in integrated initiatives that identify factors of diabetes management, treatment, and prevention. For the community, we aim to develop educational and awareness-raising programs that make a difference in our healthcare system.

Dr Qais Al Duwairi

Dr Qais Al Duwairi

Director General

In its’ five-year strategy, the Institute strives to create a platform that applies its knowledge to translational research, or bench-to-bed: from basic sciences to clinical trials point-of-care applications, scientific findings and drug discoveries. As a research-focused organization, we aspire to develop awareness-raising programs that make a difference in our healthcare system and educate the public and create awareness on diabetes management, treatment, and prevention.

Read More
ACI | Accreditation Canada International

ACI | Accreditation Canada International

ACI is a program designed to improve client outcomes and health system performance. It helps the entire organization work together to create a focus on safety and quality.
We have completed two full cycles to date. Each ACI QMENTUM cycle is completed within a 3 year period. We use this program to identify areas of strength and areas for further improvement based on the results.
We have achieved Diamond Unconditional Accreditation.

CAP | College of American Pathologists Accreditation

CAP | College of American Pathologists Accreditation

CAP Accreditation certifies laboratories that analyze samples or specimens from human beings and use methods of clinical application within their experienced specialties. This accreditation ensures that our labs maintain accuracy of test results and diagnosis, meet required standards from CLIA, FDA and OSHA, evolve with the latest technologies and medicine.
Our Clinical Laboratory has attained the CAP Accreditation.

Would you like to subscribe our mailing list?

Contact Us

Gulf Road intersecting
JassimAlBahar St. Sharq, Block 3, P.O. Box 1180 Dasman
15462 Kuwait